Related Experiment Video
Updated: Apr 7, 2026

07:44
Identifying Protein-protein Interaction Sites Using Peptide Arrays
Published on: November 18, 2014
18.8K
Mutation-induced protein interaction kinetics changes affect apoptotic network dynamic properties and facilitate
Linjie Zhao1, Tanlin Sun2, Jianfeng Pei3
1State Key Laboratory for Artificial Microstructures and Mesoscopic Physics, School of Physics, Peking University, Beijing 100871, China;
Summary
Cancer arises from genomic mutations. This study reveals how mutations affecting protein interactions disrupt the apoptosis pathway, linking molecular changes to cancer development.
Area of Science:
- Molecular Biology
- Systems Biology
- Computational Biology
Background:
- Cancer is primarily driven by genomic alterations, particularly somatic mutations.
- The precise molecular mechanisms linking mutations to oncogenesis remain incompletely understood.
- The mitochondrial apoptotic pathway is crucial for cellular regulation and a relevant model system.
Purpose of the Study:
- To quantitatively investigate the causal molecular mechanisms of mutation-induced oncogenesis.
- To integrate pathway dynamics with protein interaction kinetics using the apoptotic pathway as a case study.
- To establish the functional role of dynamic bifurcation in the apoptotic process.
Main Methods:
- Construction of a mathematical model for the regulatory network of the apoptotic pathway.
- Analysis of oncogenic mutation enrichment correlated with parameter sensitivity of dynamic bifurcation.
- Molecular dynamics simulations to evaluate the impact of mutations on protein interaction kinetics.
Main Results:
- A strong correlation was observed between oncogenic mutation enrichment in protein domains and parameter sensitivity at the bifurcation point.
- Changes in protein binding kinetics, driven by mutations and quantified by free energy changes, were identified as a major cause of apoptosis pathway dysfunction.
- Mutations within sensitive interaction domains demonstrated high oncogenic potential.
Conclusions:
- Provided a molecular framework connecting protein mutations, interaction kinetics, network dynamics, and physiological function.
- Established a link between mutation genotype and tumorigenesis phenotype.
- Elucidated key aspects of the logic underlying cancer initiation.
Related Concept Videos
Interactions Between Signaling Pathways
7.9K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.9K
The Intrinsic Apoptotic Pathway
9.2K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
9.2K
Protein Networks
4.7K
An organism can have thousands of different proteins, and these proteins must cooperate to ensure the health of an organism. Proteins bind to other proteins and form complexes to carry out their functions. Many proteins interact with multiple other proteins creating a complex network of protein interactions.
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
4.7K
PI3K/mTOR/AKT Signaling Pathway
6.4K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
6.4K
Abnormal Proliferation
5.4K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K
mTOR Signaling and Cancer Progression
5.1K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
5.1K

